<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31661379</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2222-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>8</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Emerging microbes &amp; infections</Title>
          <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification of multidrug-resistant <i>Neisseria gonorrhoeae</i> isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018.</ArticleTitle>
        <Pagination>
          <StartPage>1546</StartPage>
          <EndPage>1549</EndPage>
          <MedlinePgn>1546-1549</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2019.1681242</ELocationID>
        <Abstract>
          <AbstractText>The growing multidrug-resistant <i>Neisseria gonorrhoeae</i> is a serious global threat to gonococcal therapy. During 2017-2018, we identified a rare multidrug-resistant (ceftriaxone and azithromycin) strain (GC250) and four strains (GC185, GC195, GC196 and GC249) with both resistance to ceftriaxone and decreased susceptibility to azithromycin. All strains belonged to NG-STAR ST1143, including the mosaic <i>penA</i>-60.001, which is closely related to ceftriaxone resistance. The characterization of antimicrobial resistance (AMR) determinants and phylogenetic analysis showed these five strains were closely related to internationally spreading ceftriaxone-resistant <i>N. gonorrhoeae</i> FC428, but with higher azithromycin MIC. Findings here demonstrated that this clone not only initiated clonal expansion in China, but acquired azithromycin resistance.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Qianqin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yamei</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiu</LastName>
            <ForeName>Leshan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Chi</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fu</LastName>
            <ForeName>Yaoyang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Chuanhao</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Lingli</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Junping</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Microbes Infect</MedlineTA>
        <NlmUniqueID>101594885</NlmUniqueID>
        <ISSNLinking>2222-1751</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>75J73V1629</RegistryNumber>
          <NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>83905-01-5</RegistryNumber>
          <NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002443" MajorTopicYN="N">Ceftriaxone</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024901" MajorTopicYN="Y">Drug Resistance, Multiple, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006069" MajorTopicYN="N">Gonorrhea</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020010" MajorTopicYN="N">Heterosexuality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Neisseria gonorrhoeae</Keyword>
        <Keyword MajorTopicYN="N">azithromycin</Keyword>
        <Keyword MajorTopicYN="N">ceftriaxone</Keyword>
        <Keyword MajorTopicYN="N">multidrug-resistant</Keyword>
        <Keyword MajorTopicYN="N">phylogeny</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31661379</ArticleId>
        <ArticleId IdType="pmc">PMC6830194</ArticleId>
        <ArticleId IdType="doi">10.1080/22221751.2019.1681242</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Yin YP, Han Y, Dai XQ, et al. . 
Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018 Feb;15(2):e1002499. doi: 10.1371/journal.pmed.1002499</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1002499</ArticleId>
            <ArticleId IdType="pmc">PMC5800545</ArticleId>
            <ArticleId IdType="pubmed">29408881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Report on global sexually transmitted infection surveillance, 2018 
Geneva: World Health Organization; 2018. 
Licence: CC BY-NC-SA 3.0 IGO.</Citation>
        </Reference>
        <Reference>
          <Citation>Golparian D, Rose L, Lynam A, et al. . 
Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Euro Surveill. 2018 Nov;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.1800617</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.47.1800617</ArticleId>
            <ArticleId IdType="pmc">PMC6341943</ArticleId>
            <ArticleId IdType="pubmed">30482267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terkelsen D, Tolstrup J, Johnsen CH, et al. . 
Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Euro Surveill. 2017 Oct;22(42). doi: 10.2807/1560-7917.ES.2017.22.42.17-00659</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.42.17-00659</ArticleId>
            <ArticleId IdType="pmc">PMC5710115</ArticleId>
            <ArticleId IdType="pubmed">29067905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eyre DW, Sanderson ND, Lord E, et al. . 
Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018 Jul;23(27). doi: 10.2807/1560-7917.ES.2018.23.27.1800323</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.27.1800323</ArticleId>
            <ArticleId IdType="pmc">PMC6152157</ArticleId>
            <ArticleId IdType="pubmed">29991383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whiley DM, Jennison A, Pearson J, et al. . 
Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. Lancet Infect Dis. 2018 Jul;18(7):717–718. doi: 10.1016/S1473-3099(18)30340-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(18)30340-2</ArticleId>
            <ArticleId IdType="pubmed">29976521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakayama S, Shimuta K, Furubayashi K, et al. . 
New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016 Jul;60(7):4339–4341. doi: 10.1128/AAC.00504-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00504-16</ArticleId>
            <ArticleId IdType="pmc">PMC4914677</ArticleId>
            <ArticleId IdType="pubmed">27067334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng J-P, Yin Y-P, Chen S-C, et al. . 
A Whole-genome sequencing analysis of Neisseria gonorrhoeae isolates in China: an observational study. EClinicalMedicine. 2019;7:47–54. doi: 10.1016/j.eclinm.2019.01.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eclinm.2019.01.010</ArticleId>
            <ArticleId IdType="pmc">PMC6537553</ArticleId>
            <ArticleId IdType="pubmed">31193648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen SC, Han Y, Yuan LF, et al. . 
Identification of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, China. Emerging Infect Dis. 2019 Jul 17;25(7):1427–1429. doi: 10.3201/eid2507.190172</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2507.190172</ArticleId>
            <ArticleId IdType="pmc">PMC6590750</ArticleId>
            <ArticleId IdType="pubmed">30900979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jennison AV, Whiley D, Lahra MM, et al. . 
Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018. Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.8.1900118</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.8.1900118</ArticleId>
            <ArticleId IdType="pmc">PMC6446956</ArticleId>
            <ArticleId IdType="pubmed">30808445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee K, Nakayama SI, Osawa K, et al. . 
Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates. J Antimicrob Chemother. 2019 Jul 1;74(7):1812–1819. doi: 10.1093/jac/dkz129</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkz129</ArticleId>
            <ArticleId IdType="pubmed">31002306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefebvre B, Martin I, Demczuk W, et al. . 
Ceftriaxone-resistant Neisseria gonorrhoeae, Canada, 2017. Emerging Infect Dis. 2018 Feb;24(2):381–383. doi: 10.3201/eid2402.171756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2402.171756</ArticleId>
            <ArticleId IdType="pmc">PMC5782888</ArticleId>
            <ArticleId IdType="pubmed">29131780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lahra MM, Martin I, Demczuk W, et al. . 
Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerging Infect Dis. 2018 Apr;24(4):735–743. doi: 10.3201/eid2404.171873</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2404.171873</ArticleId>
            <ArticleId IdType="pmc">PMC5875269</ArticleId>
            <ArticleId IdType="pubmed">29553335</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
